Hwail Pharmaceutical Co. Ltd. | |
Stock Exchange | Korea Exchange |
EPS |
KRW366 |
Market Cap |
KRW114.86 B |
Shares Outstanding |
14.41 M |
Public Float |
8.8 M |
Address |
57 Jeyakgongdan 3-gil Hwaseong GY 18622 Korea, Republic Of |
Employees | - |
Website | http://www.hwail.com |
Updated | 09/14/2018 |
HWAIL PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following businesses: Pharmaceutical Raw Material, Cephalosporin Antibiotic, Functional Health Food Ingredient. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory and others. |